Loading…
Based on limited metadata, the FDA issued a warning letter to Lianhuaqingwencaps.com on July 6, 2020, regarding drug products. Without access to the full letter text or specific subject line details, the precise nature of the violations cannot be determined from the available information. The warning letter falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in this metadata. To understand the actual compliance issues cited, the complete warning letter would need to be reviewed.